文献速递临床试验与 GCP

跨诊断睡眠与昼夜节律治疗改善社区严重精神疾病结局:一项随机对照试验的研究方案

A transdiagnostic sleep and circadian treatment to improve severe mental illness outcomes in a community setting: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2016-12-20

该研究方案在阿拉米达县行为健康服务中心招募120名伴有睡眠与昼夜节律功能障碍的严重精神疾病成人,随机分为跨诊断干预(TranS-C)组(n=60)或常规照护后延迟治疗组(UC-DT,n=60)。TranS-C为模块化干预,每周一次50分钟个体 session,共8至12次。主要分析比较TranS-C相对于UC-DT对功能损害、疾病特异性症状及睡眠与昼夜节律功能的影响,并探索睡眠改善是否预测功能损害和症状减轻及其中介与调节因素。

要点

  • TranS-C为针对严重精神疾病睡眠与昼夜节律问题的跨诊断模块化干预,共8至12次每周50分钟个体治疗。
  • 研究在社区精神卫生中心开展,纳入不同DSM诊断及常见睡眠与昼夜节律问题的成人。
  • 主要分析比较TranS-C与常规照护后延迟治疗对功能损害、疾病症状及睡眠昼夜节律功能的影响。

核心结论

  • 该试验在社区环境中检验跨诊断睡眠与昼夜节律干预(TranS-C)对严重精神疾病患者功能损害、疾病特异性症状及睡眠与昼夜节律功能的作用。
  • 作者认为该试验针对严重精神疾病中睡眠与昼夜节律失调这一重要且研究不足的机制,采用新型跨诊断治疗方法,以促进研究与临床实践之间的衔接。

研究设计与样本

  • 研究为随机对照试验方案,在阿拉米达县行为健康服务中心(ACBHCS)这一社区精神卫生中心开展。
  • 计划纳入120名诊断为严重精神疾病且存在睡眠与昼夜节律功能障碍的成人,随机分配至TranS-C组(n=60)或6个月常规照护后延迟TranS-C治疗组(UC-DT,n=60)。
  • TranS-C为模块化干预,以每周一次、每次50分钟的个体 session 形式实施,共8至12次。
  • 所有参与者在治疗前、治疗结束后立即及6个月后接受评估。
  • 主要分析比较TranS-C相对于UC-DT对功能损害、疾病特异性症状及睡眠与昼夜节律功能的影响;探索性分析检验睡眠与昼夜节律功能改善是否预测功能损害和疾病特异性症状的减轻,以及干预效应是否由睡眠与昼夜节律功能改善所中介、是否受既往报告的风险因素(人口学、症状严重程度、药物、精神与躯体共病)所调节。

主要发现

  • 原文为研究方案,未报告结果数据。

关键数值与推荐

  • TranS-C实施方式为每周一次、每次50分钟的个体 session,共8至12次。
  • UC-DT为6个月常规照护后延迟给予TranS-C治疗。
  • 评估时间点为治疗前、治疗结束后立即及6个月后。

临床怎么用

  • 原文为研究方案,未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe mental illness (SMI) is common, chronic and difficult to treat. Sleep and circadian dysfunctions are prominent correlates of SMI, yet have been minimally studied in ways that reflect the complexity of the sleep problems experienced. Prior treatment studies have been disorder-focused-they have treated a specific sleep problem in a specific diagnostic group. However, real life sleep and circadianproblems are not so neatly categorized, particularly in SMI where features of insomnia overlap with hypersomnia, delayed sleep phase and irregular sleep-wake schedules. Accordingly, the aim of this studyprotocol is to test the hypothesis that a Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) will improve functional impairment, disorder-focused symptoms and sleep and circadian functioning. Participants across DSM diagnoses and across common sleep and circadian problems are eligible. The elements of TranS-C are efficacious across SMI in research settings with research-based providers. The next step is to test TranS-C in a community setting. Accordingly, this study is being conducted within Alameda County Behavioral Health Care Services (ACBHCS), the Community Mental Health Centre (CMHC) for Alameda County. METHODS/DESIGN: 120 adults diagnosed with SMI and sleep and circadian dysfunction within ACBHCS will be randomly allocated to TranS-C (n = 60) or 6-months of Usual Care followed by Delayed Treatment with TranS-C (UC-DT; n = 60). TranS-C is modularized and delivered across eight to twelve 50-minute, weekly, individual sessions. All participants will be assessed before and immediately following treatment and again 6 months later. Primary analysis will examine whether TranS-C significantly improves functional impairment, disorder-specific symptoms and sleep and circadian functioning, relative to UC-DT. Exploratory analysis will examine whether improvements in sleep and circadian functioning predict reduction in functional impairment and disorder-specific symptoms, and whether the intervention effects are mediated by improved sleep and circadian functioning and moderated by previously reported risk factors (demographics, symptom severity, medications, psychiatric and medical comorbidity). DISCUSSION: This trial tests an important and understudied mechanism-dysregulated sleep and circadian rhythms-in SMI, a novel transdiagnostic treatment approach, in a community setting so as to contribute to the goal of bridging the gap between research and practice. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02469233 . Registered on 9 June 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Harvey AG, Hein K, Dong L, et al. A transdiagnostic sleep and circadian treatment to improve severe mental illness outcomes in a community setting: study protocol for a randomized controlled trial. Trials. 2016. PMID: 27998295. doi:10.1186/s13063-016-1690-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。